Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Kemeny HR, Elsamadicy AA, Farber SH, Champion CD, et al. Clin Cancer Res 2020;26:1141-1151.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kemeny HR, Elsamadicy AA, Farber SH, Champion CD, et al. Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Clin Cancer Res 2020;26:1141-1151.
PMID: 31744830